Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | polymerase (DNA directed), beta | Starlite/ChEMBL | No references |
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | polymerase (DNA directed), beta | 335 aa | 303 aa | 32.3 % |
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | hypothetical protein, conserved | 0.0294 | 0.3155 | 0.7721 |
Mycobacterium ulcerans | hypothetical protein | 0.0192 | 0.1798 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.0223 | 1 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.0811 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0365 | 0.4086 | 1 |
Leishmania major | mitochondrial DNA polymerase beta-PAK, putative | 0.0173 | 0.1539 | 0.3767 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0223 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.0223 | 0.0223 |
Leishmania major | mitochondrial DNA polymerase beta | 0.0365 | 0.4086 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0173 | 0.1539 | 0.3767 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0056 | 0 | 0.5 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0365 | 0.4086 | 1 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.0223 | 0.0546 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0056 | 0 | 0.5 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Giardia lamblia | GTOR | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.0223 | 0.0223 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0223 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0056 | 0 | 0.5 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0056 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0284 | 0.3011 | 0.7369 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0192 | 0.1798 | 1 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0365 | 0.4086 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0173 | 0.1539 | 0.3767 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0062 | 0.008 | 0.0195 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0056 | 0 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0059 | 0.0031 | 0.1385 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.1 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.